New Focus on Government, Non-Profits Lands Caprion $12.9M NIAID Contract | GenomeWeb
Caprion Proteomics announced last week it has been awarded a $12.9 million contract from the National Institute of Allergy and Infectious Diseases as the company plumbs a funding segment that it has largely ignored to date.
The five-year contract, which directs Caprion to find and identify candidate protein biomarkers for diseases that can be caused by biopathogens, is just the second in the history of the firm dating back to when it was housed within Caprion Pharmaceuticals.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.